Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Dr. Joachim Luithle
Advertisement
SVP, Head of Clinical Development Operations, Bayer
Articles by Dr. Joachim Luithle
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
2
Assay Reproducibility in Hemostasis Diagnostics: Practical Methods to Reduce Variability and Strengthen Trial Outcomes
3
2025 SCRS Global Site Solutions Summit: Best Practices for Building Strong Site Partnerships and Choosing the Right Technology
4
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
